BMRN - BioMarin Pharmaceutical Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue1,116,854889,895749,284
Cost of Revenue209,620152,008122,267
Gross Profit907,234737,887627,017
Operating Expenses
Research Development661,905634,806461,543
Selling General and Administrative476,593402,271302,156
Non Recurring599,118198,700198,700
Others-26,953-17,69023,709
Total Operating Expenses1,710,6631,218,087-
Operating Income or Loss-803,429-110,702-92,891
Income from Continuing Operations
Total Other Income/Expenses Net12,416364,53773,042
Earnings Before Interest and Taxes-791,551-116,480-88,226
Interest Expense39,49938,24436,642
Income Before Tax-831,050-154,724-124,868
Income Tax Expense-200,84017,0759,101
Minority Interest---
Net Income From Continuing Ops-630,748-172,616-134,846
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-630,210-171,799-133,969
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-630,210-171,799-133,969